The report highlights the company's commitment to sustainable growth and its efforts in value creation, value preservation, and strengthening of corporate governance. Key highlights include a fourth consecutive year of growing sales and profits, the expansion of OPDIVO indications, and the establishment of a direct sales system in the United States. The report also outlines the company's strategy for achieving a decarbonized society by 2050, which includes increasing the use of renewable energy and reducing greenhouse gas emissions.
Issuing Company Ono Pharmaceutical Co., Ltd.
Report Type Integrated Report
Report Language EN
Report Filesize 9.08 MB
No. of Pages 57 pages
Reporting periodApril 1, 2021-March 31, 2022
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; TCFD
Materiality Assessmenttrue